Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$882KFederal grants as PI4 awards
0Patents grantedNone matched
67Papers2,482 citations
Federal awards and patents by year
AwardsPatents
4 awards · $882K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 1, 2018 | NIH | STTR Phase I Building an evidentiary case for circulating GHBP as a biomarker for drug-associated stunting of growth | $225K | REVERAGEN BIOPHARMA, INC. with SUNY Binghamton |
| Jun 1, 2018 | NIH | SBIR Phase I Establishing a biomarker framework for feasibility studies of vamorolone in vasculitis | $178K | REVERAGEN BIOPHARMA, INC. |
| Apr 1, 2016 | NIH | STTR Phase I Effectiveness of VBP15, a dissociative steroidal analogue, on chronic inflammation in a mouse model of multiple sclerosis | $254K | REVERAGEN BIOPHARMA, INC. |
| Sep 1, 2015 | NIH | STTR Phase I Effectiveness of VBP15, a dissociative steroidal analogue, on inflammation in a mouse model of arthritis | $225K | REVERAGEN BIOPHARMA, INC. with CHILDREN'S RESEARCH INSTITUTE |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,902
Awards as PI#566
Patents#273
Companies
- REVERAGEN BIOPHARMA, INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.